Showing results (321-330 of 462) with videos related to
Sort By:
Pageof 47
Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancerEdgar Ben-Josef, Anthony F Shields, Ulka Vaishampayan, et al.American Journal of Translational Research|September 10, 2011
Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanismAsfar S Azmi, Shadan Ali, Sanjeev Banerjee, et al.Journal of the National Cancer Institute|November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I CommitteeP A Philip, D Rea, P Thavasu, et al.Cancer Research|December 1, 1993
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopyP A Philip, C H Thompson, J Carmichael, et al.American Journal of Clinical Oncology|October 7, 2006
A phase II study of docetaxel, doxorubicin, and infusional 5-fluorouracil in the treatment of patients with locally advanced breast cancerLata Chandi Thatai, Priya Vishnubhotla, Laura Biernat, et al.Transgenic Research|June 11, 2002
Avidin expressed in transgenic tobacco leaves confers resistance to two noctuid pests, Helicoverpa armigera and Spodoptera lituraElisabeth P J Burgess, Louise A Malone, John T Christeller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II study of erlotinib in patients with advanced biliary cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.Brain Research|March 27, 1992
A cocaine analog and a GBR analog label the same protein in rat striatal membranesA Patel, J W Boja, J Lever, et al.Oncogene|September 7, 2010
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapyA S Azmi, P A Philip, F W J Beck, et al.Pageof 47